TOP STORIES

• COMMENTARY Sumitomo Dainippon Aims at 100 Billion Yen Sales from “Frontier Business,” Making Challenge Beyond Drugs
  September 9, 2020

• REGULATORY Sakigake Status Should Not Be Granted to Novartis Products until It Takes Prevention Measures for Approval Delay: Pharma Bureau Chief
  September 8, 2020

• ORGANIZATION JPMA to Commit to Growth of Research-Driven Pharma Industry, R&D of COVID-19 Drugs, Vaccines: Director General
  September 7, 2020

• BUSINESS Blackstone Setting Sights on IPO of Takeda Consumer Healthcare Within 5-10 Years
  September 4, 2020

• REGULATORY Will Temporary Measures in R&D Tax Credit System Be Extended? Enthusiasm for R&D Investment Could Determine Outcome
  September 3, 2020

• BUSINESS Mitsubishi Tanabe’s HIF-PH Inhibitor Hit by Shortage Days after Launch on Better-than-Expected Demand
  September 2, 2020

• BUSINESS Japan Sees Showdown of 3 HIF-PH Inhibitors as 2 New Drugs Enter Market
  September 1, 2020

• REGULATORY Japan in Talks to Secure 40 Million-Plus Doses of Moderna Vaccine via Takeda: Minister
  August 31, 2020

• BUSINESS Nichi-Iko to Revamp Quality Control System after Massive Recalls by Leveraging Teva Takeda Plant
  August 28, 2020

• REGULATORY MHLW to Accept Sakigake Applications All Year Long under Amended PMD Law
  August 27, 2020

• BUSINESS 2 More HIF-PH Inhibitors, Enerzair, Enspryng and More Now Available in Japan
  August 27, 2020

• BUSINESS As Entresto Hits Japan Market, Novartis Poised to Tap All Channels to Push Global Blockbuster
  August 26, 2020

• COMMENTARY COVID-19 Pandemic to Test True Value of MHLW’s Officers with Medical/Pharma Backgrounds
  August 26, 2020

• BUSINESS Drug Makers Taking Mixed Disclosure Policies for Coronavirus Infections
  August 25, 2020

• BUSINESS Takeda to Sell Japan OTC Biz to Blackstone, Weber Says It’s the Right Choice
  August 25, 2020

• BUSINESS Japan Drug Makers’ Q1 Profit Surges on Voluntary Bans on Doctor Calls: Jiho Tally
  August 24, 2020

• REGULATORY Japan to Look at H1N1 Flu Rules to Consider Indemnity for COVID-19 Vaccine Makers
  August 24, 2020

• REGULATORY Japan Plans to Provide Indemnity to Coronavirus Vaccine Suppliers
  August 21, 2020

• BUSINESS Boehringer’s Ofev Already Hits Japan Peak Sales Outlook, Momentum Likely to Continue with New Indications
  August 20, 2020

• REGULATORY Entresto, Enerzair, 2 More HIF-PH Inhibitors OK'ed for Listing on August 26
  August 19, 2020

ページ

• « 先頭
• ‹ Prev
• …
• 104
• 105
• 106
• 107
• 108
• 109
• 110
• 111
• 112
• …
• Next ›
• 最終 »